Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation. Kiniwa Y, Nakamura K, Mikoshiba A, Ashida A, et al. BMC Cancer 2021;21:287.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kiniwa Y, Nakamura K, Mikoshiba A, Ashida A, et al. Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation. BMC Cancer 2021;21:287.
PMID: 33731038